Insmed Net Income increased by 50.2% to -$163.56M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 36.3%, from -$256.58M to -$163.56M. Over 4 years (FY 2021 to FY 2025), Net Income shows a downward trend with a 30.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$117.32M | -$112.71M | -$112.98M | -$94.62M | -$95.65M | -$131.15M | -$160.12M | -$159.76M | -$244.81M | -$158.93M | -$186.06M | -$157.09M | -$300.61M | -$220.52M | -$235.55M | -$256.58M | -$321.69M | -$370.02M | -$328.49M | -$163.56M |
| QoQ Change | — | +3.9% | -0.2% | +16.2% | -1.1% | -37.1% | -22.1% | +0.2% | -53.2% | +35.1% | -17.1% | +15.6% | -91.4% | +26.6% | -6.8% | -8.9% | -25.4% | -15.0% | +11.2% | +50.2% |
| YoY Change | — | — | — | — | +18.5% | -16.4% | -41.7% | -68.8% | -156.0% | -21.2% | -16.2% | +1.7% | -22.8% | -38.8% | -26.6% | -63.3% | -7.0% | -67.8% | -39.5% | +36.3% |